CNBC Awaaz reported citing sources that the health ministry is examining a proposal to limit the margin that hospitals can charge on a wide range of medical devices.
The move is aimed at addressing overbilling practices that have drawn increasing scrutiny in recent years.
The government is evaluating a framework under which hospitals would not be allowed to bill beyond a fixed percentage over the cost or landing price of medical products.
The proposed cap may cover both everyday medical consumables such as syringes, cannulas and gloves, as well as high-value devices including pacemakers and heart valves, as per the report.
Officials are consulting various stakeholders, including the medical device industry and insurance companies, to determine how such a cap could be implemented effectively. The effort is part of a broader push to bring transparency to hospital billing and reduce the financial burden on patients.
Also Read: Hospital bills are now too expensive for insurers too
Investigations have shown that hospitals in some cases charge 10 to 30 times the actual cost of certain medical consumables. CNBC Awaaz reported examples where a syringe costing about ₹3 may be billed at ₹30, while an IV cannula with a base cost of roughly ₹6 could be billed up to ₹120.
For high-value devices, the differences can be even more striking, with pacemakers costing around ₹25,000 reportedly billed close to ₹2 lakh, and imported heart valves costing about ₹4 lakh billed as high as ₹26–30 lakh, as per CNBC Awaaz.
The proposed cap on hospital billing, if implemented, could help reduce treatment costs, ease pressure on insurance premiums and improve transparency in India’s healthcare system.
Rising hospital costs straining insurance ecosystem
The issue of hospital billing has also begun affecting the health insurance sector. Rising medical inflation — estimated at around 14-15% annually — is pushing insurers to increase health insurance premiums by 10-15% over the next 12-18 months, CNBC-TV18 reported earlier.
Experts said that increasing hospital charges, advanced treatments and higher claims frequency are key drivers of premium revisions.
Insurers are also facing growing pressure from higher claim amounts and costly hospital procedures. Average hospital claims have risen significantly in recent years, while disputes between hospitals and insurers over pricing and settlement rates have become more frequent.
Industry estimates show that the average cost of a family floater health insurance policy has risen from around ₹15,000 in 2021 to more than ₹22,000 in 2025.
Investment flows and policy reforms
Despite cost concerns, India’s insurance and healthcare ecosystem continues to attract significant investment. Bengaluru-based insurtech startup Plum recently raised ₹193 crore in a Series B funding round led by Peak XV Partners, signalling strong private equity interest in the sector.
Policy reforms are also underway. Parliament passed legislation to raise the foreign direct investment (FDI) limit in the insurance sector from 74% to 100% in December 2025. The move was aimed at boosting capital inflows and expanding insurance coverage.
